Royal Bank Of Canada Initiates Coverage on Xylem (NYSE:XYL)

Investment analysts at Royal Bank Of Canada began coverage on shares of Xylem (NYSE:XYL) in a report released on Wednesday, Zacks reports. The brokerage set a “moderate buy” rating on the industrial products company’s stock.

Several other research analysts have also commented on XYL. Stifel Nicolaus cut their price objective on Xylem from $141.00 to $114.00 and set a “buy” rating on the stock in a research report on Wednesday. Oppenheimer decreased their price target on Xylem from $150.00 to $135.00 and set an “outperform” rating for the company in a report on Wednesday. Robert W. Baird set a $123.00 price objective on shares of Xylem in a research report on Wednesday. The Goldman Sachs Group dropped their price objective on shares of Xylem from $160.00 to $138.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Barclays set a $104.00 target price on shares of Xylem and gave the company an “equal weight” rating in a research note on Wednesday. Nine investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Xylem has an average rating of “Hold” and an average price target of $122.31.

Xylem Stock Performance

Shares of NYSE XYL opened at $88.31 on Wednesday. The company has a market cap of $20.62 billion, a PE ratio of 21.03, a price-to-earnings-growth ratio of 1.75 and a beta of 1.00. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24. Xylem has a 12 month low of $87.40 and a 12 month high of $154.27. The company has a 50-day simple moving average of $105.98 and a 200-day simple moving average of $118.05.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a return on equity of 11.77% and a net margin of 11.15%. The business had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. During the same period in the prior year, the company earned $1.37 EPS. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. On average, equities analysts anticipate that Xylem will post 5.65 earnings per share for the current year.

Institutional Trading of Xylem

A number of hedge funds and other institutional investors have recently made changes to their positions in XYL. MGO One Seven LLC increased its position in shares of Xylem by 48.1% in the 3rd quarter. MGO One Seven LLC now owns 2,706 shares of the industrial products company’s stock worth $274,000 after purchasing an additional 879 shares during the last quarter. Aprio Wealth Management LLC raised its stake in shares of Xylem by 6.2% in the 3rd quarter. Aprio Wealth Management LLC now owns 2,114 shares of the industrial products company’s stock valued at $214,000 after purchasing an additional 123 shares in the last quarter. Renaissance Investment Group LLC lifted its position in shares of Xylem by 5.8% during the third quarter. Renaissance Investment Group LLC now owns 88,230 shares of the industrial products company’s stock worth $8,935,000 after purchasing an additional 4,823 shares during the last quarter. Soltis Investment Advisors LLC bought a new position in shares of Xylem during the third quarter worth about $6,895,000. Finally, Choreo LLC acquired a new position in Xylem in the third quarter worth about $248,000. Institutional investors own 87.96% of the company’s stock.

Xylem News Summary

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Orders increased 10% during the quarter, indicating that underlying demand remains resilient despite near-term customer caution and project-timing issues. Xylem Q3 2026 orders report
• Positive Sentiment: Management announced divestitures and a new three-segment structure intended to simplify the portfolio and improve strategic focus. The restructuring could support longer-term execution, although investors may face transition costs. Xylem announces divestitures and new segment structure
• Neutral Sentiment: Several analysts retained bullish ratings, including “buy” or “outperform,” but reduced their price targets. Citigroup cut its target to $130, BNP Paribas Exane to $135, Stifel to $114, RBC to $125 and Oppenheimer to $135. Analyst price target changes
• Negative Sentiment: Third-quarter revenue was $2.20 billion, below the approximately $2.28 billion consensus estimate and down 3% year over year. Adjusted EPS of $1.44 also narrowly missed expectations. Weak metering demand and delayed projects weighed on results. Xylem Q3 results
• Negative Sentiment: Xylem lowered its 2026 revenue and earnings outlook and issued weaker fourth-quarter expectations, signaling that customer pullbacks and operating headwinds may persist. Xylem lowers 2026 outlook
• Negative Sentiment: JPMorgan downgraded Xylem to neutral and cut its target to $90 from $118, while unusually heavy put-option activity and a reported securities-law investigation added to investor caution. JPMorgan downgrades Xylem

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.